| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.2B | $7.8B | $8.2B | $8.0B | $6.6B | $6.9B | $6.5B | $6.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.8B | $1.5B | $1.6B | $2.1B | $2.3B | $1.1B | $1.8B | $1.7B |
| EPS (Basic) | $3.90 | $3.05 | $3.14 | $4.12 | $5.18 | $2.22 | $3.82 | $3.54 |
| EPS (Diluted) | $3.86 | $3.03 | $3.13 | $4.10 | $5.16 | $2.22 | $3.81 | $3.52 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $226.4B | $217.5B | $222.0B | $226.7B | $188.4B | $183.3B | $165.7B | $160.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | $4.1B |
| Total Liabilities | $200.0B | $193.3B | $197.6B | $203.0B | $165.0B | $160.7B | $143.5B | $139.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $26.3B | $24.3B | $24.3B | $23.7B | $23.4B | $22.7B | $22.2B | $20.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.2B | $2.0B | $3.0B | $4.1B | $2.3B | $0.1B | $1.7B | $1.8B |
| Investing Cash Flow | $-6.0B | $3.0B | $5.2B | $-12.6B | $-10.5B | $-6.1B | $-3.9B | $-7.1B |
| Capital Expenditures | — | — | — | — | — | — | $0.1B | — |
| Financing Cash Flow | $5.9B | $-6.0B | $-7.1B | $9.9B | $4.6B | $15.4B | $1.5B | $6.4B |